Created in 2002 (United States), MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE own 126 sister brands and 17477 competing brands. The MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE brand is owned by Celgene, a company listed in New York. MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE belongs to the Drug Manufacturers business sector.
News from the brand MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE
Recent tweets
Celgene
(MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE)
.
All news 
Celgene
(MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE)
Recent tweets
Celgene
(MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE)
.
Stock exchange: More information on Celgene
(MULTIPLE PATHWAYS, MULTIPLE TARGETS: DRUG DISCOVERY FOR CELGENE)
